Pharma firms cleared to market anastrozole generic
Mylan Pharmaceuticals Inc., Breckenridge Pharmaceutical Inc. and APP Pharmaceuticals have received approval from the Food and Drug Administration to offer anastrozole tablets, a treatment for early breast cancer. The companies said Tuesday they plan to market 1 mg anastrozole tablets.